Rigel Pharmaceuticals
RIGL
#7027
Rank
HK$3.01 B
Marketcap
HK$171.58
Share price
42.94%
Change (1 day)
167.96%
Change (1 year)

Earnings for Rigel Pharmaceuticals (RIGL)

Earnings in 2024 (TTM): -HK$51.14 Million

According to Rigel Pharmaceuticals's latest financial reports the company's current earnings are HK$0.13 Billion. In 2023 the company made an earning of -HK$0.15 Billion, an increase over its 2022 earnings that were of -HK$0.43 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Rigel Pharmaceuticals from 2000 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -HK$51.14 Million-63.9%
2023 -HK$0.15 Billion-66.79%
2022 -HK$0.43 Billion340.73%
2021 -HK$96.79 Million-56.15%
2020 -HK$0.23 Billion-57.34%
2019 -HK$0.52 Billion-7.66%
2018 -HK$0.57 Billion-9.47%
2017 -HK$0.62 Billion24.46%
2016 -HK$0.5 Billion23.63%
2015 -HK$0.41 Billion-43.29%
2014 -HK$0.71 Billion2.5%
2013 -HK$0.7 Billion
2010 HK$0.29 B-133.97%
2009 -HK$0.87 Billion-18.49%
2008 -HK$1.07 Billion71.91%
2007 -HK$0.62 Billion84.74%
2006 -HK$0.34 Billion-10.17%
2005 -HK$0.38 Billion-15.73%
2004 -HK$0.45 Billion39.29%
2003 -HK$0.32 Billion10.3%
2002 -HK$0.29 Billion48.3%
2001 -HK$0.2 Billion-2.13%
2000 -HK$0.2 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-HK$1.02 Billion 1,902.15%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$1.61 Billion 3,065.12%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$73.09 B-144,236.13%๐Ÿ‡ฌ๐Ÿ‡ง UK
HK$36.37 B-71,830.80%๐Ÿ‡บ๐Ÿ‡ธ USA